Vanderbilt researchers propose that cellular signaling pathways are amplified by a “conveyor belt” mechanism that exchanges active and inactive enzymes.

A greater understanding of the mechanisms and cell types involved in returning adipose (fatty) tissue to the lean state may lead to more effective treatments for obesity.

Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension, a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs.

David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.

New research sheds light on how changes in blood vessel forces enhance immune cell activation and promote hypertension.

The Greater Nashville Heart Walk is set for Saturday, Sept. 15 on the Vanderbilt campus to raise money and awareness about cardiovascular disease and stroke.

Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs.